EUVIMEDEUVIMED entdecken
Open Access

Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis

Jui M Dave iD, Raja Chakraborty, Alex Agyemang iD, Aglaia Ntokou iD, Junichi Saito iD, Praveen Ballabh iD, Kathleen A Martin iD, Daniel M Greif iD

Stroke · 2024

DOI: 10.1161/strokeaha.123.045248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2024. Verfasst von Jui M Dave und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), …. Hauptthemen laut MEDLINE: Pericytes, Angiopoietin-2, Transforming Growth Factor beta. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: TGF (transforming growth factor)-β pathway is central to blood-brain barrier development as it regulates cross talk between pericytes and endothelial cells. Murine embryos lacking TGFβ receptor Alk5 (activin receptor-like kinase 5) in brain pericytes (mutants) display endothelial cell hyperproliferation, abnormal vessel morphology, and gross germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH), leading to perinatal lethality. Mechanisms underlying how ALK5 signaling in pericytes noncell autonomously regulates endothelial cell behavior remain elusive. METHODS: Transcriptomic analysis of human brain pericytes with ALK5 silencing identified differential gene expression. Brain vascular cells isolated from mutant embryonic mice with GMH-IVH and preterm human IVH brain samples were utilized for target validation. Finally, pharmacological and genetic inhibition was used to study the therapeutic effects on GMH-IVH pathology. RESULTS: Herein, we establish that the TGFβ/ALK5 pathway robustly represses ANGPT2 (angiopoietin-2) in pericytes via epigenetic remodeling. TGFβ-driven SMAD (suppressor of mothers against decapentaplegic) 3/4 associates with TGIF1 (TGFβ-induced factor homeobox 1) and HDAC (histone deacetylase) 5 to form a corepressor complex at the Angpt2 promoter, resulting in promoter deacetylation and gene repression. Moreover, murine and human germinal matrix vessels display increased ANGPT2 expression during GMH-IVH. Isolation of vascular cells from murine germinal matrix identifies pericytes as a cellular source of excessive ANGPT2. In addition, mutant endothelial cells exhibit higher phosphorylated TIE2 (tyrosine protein kinase receptor). Pharmacological or genetic inhibition of ANGPT2 in mutants improves germinal matrix vessel morphology and attenuates GMH pathogenesis. Importantly, genetic ablation of Angpt2 in mutant pericytes prevents perinatal lethality, prolonging survival. CONCLUSIONS: This study demonstrates that TGFβ-mediated ANGPT2 repression in pericytes is critical for maintaining blood-brain barrier integrity and identifies pericyte-derived ANGPT2 as an important pathological target for GMH-IVH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericytesAngiopoietin-2Transforming Growth Factor betaAnimalsMiceHumansReceptor, Transforming Growth Factor-beta Type ICerebral HemorrhageSignal TransductionReceptors, Transforming Growth Factor betaEndothelial CellsProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

angiogenesisangiopoietin-2blood-brain barrierendothelial cellsepigenomicsintrancranial hemorrhagespericytes

Substanzen

Angiopoietin-2Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouseReceptors, Transforming Growth Factor betaANGPT2 protein, humanAngpt2 protein, mouseProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Internal Medicine, Yale Cardiovascular Research Center, Section of Cardiovascular Medicine (J.M.D., R.C., A.N., J.S., K.A.M., D.M.G.), Yale University, New Haven, CT.
  • Department of Genetics (J.M.D., A.N., J.S., D.M.G.), Yale University, New Haven, CT.
  • Department of Pediatrics (A.A., P.B.), Albert Einstein College of Medicine, Bronx, NY.
  • Dominick P. Purpura Department of Neuroscience (P.B.), Albert Einstein College of Medicine, Bronx, NY.

ORCID-Profile: Jui M Dave, Alex Agyemang, Aglaia Ntokou, Junichi Saito, Praveen Ballabh, Kathleen A Martin, Daniel M Greif

Förderung

  • NINDS NIH HHS
  • NHLBI NIH HHS
  • NICHD NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Dave, J. M., Chakraborty, R., Agyemang, A., Ntokou, A., Saito, J., Ballabh, P., Martin, K. A., & Greif, D. M. (2024). Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis. Stroke. https://doi.org/10.1161/strokeaha.123.045248

Vancouver

Dave JM, Chakraborty R, Agyemang A, Ntokou A, Saito J, Ballabh P, et al. Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis. Stroke. 2024. doi:10.1161/strokeaha.123.045248

BibTeX
@article{Dave2024,
  author = {Dave, Jui M and Chakraborty, Raja and Agyemang, Alex and Ntokou, Aglaia and Saito, Junichi and Ballabh, Praveen and Martin, Kathleen A and Greif, Daniel M},
  title = {Loss of TGFβ-Mediated Repression of Angiopoietin-2 in Pericytes Underlies Germinal Matrix Hemorrhage Pathogenesis},
  journal = {Stroke},
  year = {2024},
  doi = {10.1161/strokeaha.123.045248}
}
Kostenlos starten →